Supernus Pharmaceuticals, Inc. (SUPN)
57.20
+3.90
(+7.32%)
USD |
NASDAQ |
Feb 25, 13:25
Supernus Pharmaceuticals Market Cap : 3.280B for Feb. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Biogen, Inc. | 27.98B |
| Catalyst Pharmaceuticals, Inc. | 3.042B |
| Oncotelic Therapeutics, Inc. | 21.20M |
| Vertex Pharmaceuticals, Inc. | 122.93B |
| Krystal Biotech, Inc. | 7.954B |
Market Cap Related Metrics
| PS Ratio | 4.732 |
| Price to Book Value | 3.125 |
| Price to Free Cash Flow | 45.58 |
| Price | 57.20 |
| Earnings Yield | -0.60% |